Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase NA 1Phase EARLY_PHASE1 1

Status

Completed 3Unknown 1

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Breast 23Genitourinary 16Gastrointestinal 16Other hematologic neoplasm 14Lymphoid 11Myeloid 5Dermatologic 5CNS 5Gynecologic 4Classical hematology 3Other 2Tumor-Agnostic 1Thoracic 1Plasma cell 1Other neoplasm 1Endocrine 1

Conditions

Ovarian Neoplasms 3Osteoporosis 1Myelodysplastic Syndromes 1Lymphoma 1Leukemia 1Carcinoma, Ovarian Epithelial 1Cachexia 1

Interventions

Paclitaxel 268Carboplatin 264Cisplatin 194Bevacizumab 135pembrolizumab 99Surveys and Questionnaires 84Radiotherapy 77Cyclophosphamide 75olaparib 67Blood Specimen Collection 65Drug Therapy 62Hyperthermic Intraperitoneal Chemotherapy 60Gemcitabine 60niraparib 56Topotecan 56Brachytherapy 54liposomal doxorubicin 52Taxes 47Docetaxel 46Magnetic Resonance Spectroscopy 43Letrozole 36Cytoreduction Surgical Procedures 36Filgrastim 33Biopsy 33Surgical Procedures, Operative 32durvalumab 31Specimen Handling 31Doxorubicin 31Nivolumab 30Albumin-Bound Paclitaxel 28

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
OTHER × Cholecalciferol × Gynecologic × Clear all
NCT04864431 2022-06-22

VitD

Indonesia University

Phase NA Unknown
54 enrolled
Gynecologic

Carcinoma, Ovarian Epithelial, Cachexia

NCT03028519 2022-04-19

Vitamin D, Leptin, Vitamin D Receptor Polymorphism, and Treatment-Related Morbidity in Ovarian Cancer

University of Oklahoma

Phase EARLY_PHASE1 Completed
81 enrolled
Gynecologic

Ovarian Neoplasms

NCT00321932 2017-03-09

Zoledronic Acid in Preventing Osteoporosis in Patients Undergoing Donor Stem Cell Transplant

University of Minnesota

Phase 2 Completed
61 enrolled 16 charts
GynecologicLymphoidMyeloidOther hematologic neoplasm

Leukemia, Lymphoma, Myelodysplastic Syndromes, Osteoporosis, Ovarian Neoplasms

NCT00593580 2011-06-29

FOSAVANCE

British Columbia Cancer Agency

Phase 2 Completed
60 enrolled
Gynecologic

Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡